Institutional members access full text with Ovid®

Share this article on:

Comparative Effectiveness and Cost-Effective Analyses: 17.3% and Counting!

Brown, Gary C. MD, MBA; Brown, Melissa M. MD, MN, MBA; Kertes, Peter J. MD, CM, FRCSC; Lieske, Heidi MBA; Lieske, P. Alexander MBA

doi: 10.1097/IEB.0b013e318212d334
Value-Based Medicine Analysis
© 2011 Lippincott Williams & Wilkins, Inc.